Protective effects of L-arabinose in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats

References

• Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005; 111: 1448–54. [PubMed Abstract].
   Google Scholar
• Unger RH. Lipotoxic diseases. Annu Rev Med. 2002; 53: 319–36. [PubMed Abstract].
   Google Scholar
• Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, etal. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med. 2004; 140: 167–74. [PubMed Abstract].
   Google Scholar
• Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, etal. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007; 49: 403–14. [PubMed Abstract].
   Google Scholar
• Kanoski SE, Davidson TL. Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity. Physiol Behav. 2011; 103: 59–68. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Alzoubi KH, Abdul-Razzak KK, Khabour OF, Al-Tuweiq GM, Alzubi MA, Alkadhi KA. Caffeine prevents cognitive impairment induced by chronic psychosocial stress and/or high fat-high carbohydrate diet. Behav Brain Res. 2013; 237: 7–14. [PubMed Abstract].
   Google Scholar
• Alzoubi KH, Khabour OF, Salah HA, Abu Rashid BE. The combined effect of sleep deprivation and western diet on spatial learning and memory: role of BDNF and oxidative stress. J Mol Neurosci. 2012; 50: 124–33. [PubMed Abstract].
   Google Scholar
• Sutherland JP, McKinley B, Eckel RH. The metabolic syndrome and inflammation. Metab Syndr Relat Disord. 2004; 2: 82–104. [PubMed Abstract].
   Google Scholar
• Marcaurelle LA, Johannes CW. Application of natural product-inspired diversity-oriented synthesis to drug discovery. Prog Drug Res. 2008; 66: 187–216. [PubMed Abstract].
   Google Scholar
• Song YB, Kim B, Choi MJ, Song YO, Cho EJ. Protective effect of arabinose and sugar beet pulp against high glucose-induced oxidative stress in LLC-PK1 cells. Food Chem. 2012; 134: 189–94.
   Web of Science ®Google Scholar
• Poudyal H, Panchal SK, Ward LC, Waanders J, Brown L. Chronic high-carbohydrate, high-fat feeding in rats induces reversible metabolic, cardiovascular, and liver changes. Am J Physiol Endoc Metab. 2012; 302: E1472–82.
   Web of Science ®Google Scholar
• Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, etal. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003; 112: 1821–30. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Cong WN, Tao RY, Tian JY, Liu GT, Ye F. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice. Life Sci. 2008; 82: 983–90. [PubMed Abstract].
   Google Scholar
• Ryu MH, Daily W, Cha YS. Effect of starvation on hepatic acyl-CoA synthetase, carnitine palmitoyltransferase-I, and acetyl-CoA carboxylase mRNA levels in rats. Nutrition. 2005; 21: 537–42. [PubMed Abstract].
   Google Scholar
• Huang PL. A comprehensive definition for metabolic syndrome. Dis Models Mech. 2009; 2: 231–7.
   PubMed Web of Science ®Google Scholar
• Bhattacharya J, Sood N. Who pays for obesity?. J Econ Perspect. 2011; 25: 139–57. [PubMed Abstract].
   Google Scholar
• Liu X, Zhu D, Sun L, Gao Y, Wang C. Effect of L-arabinose on the postprandial blood glucose and body weight. J Hyg Res. 2013; 42: 295–7.
   Google Scholar
• Krog-Mikkelsen I, Hels O, Tetens I, Holst JJ, Andersen JR, Bukhave K. The effects of L-arabinose on intestinal sucrase activity: dose-response studies in vitro and in humans. Am J Clin Nutr. 2011; 94: 472–8. [PubMed Abstract].
   Google Scholar
• Seri K, Sanai K, Matsuo N, Kawakubo K, Xue C, Inoue S. L-arabinose selectively inhibits intestinal sucrase in an uncompetitive manner and suppresses glycemic response after sucrose ingestion in animals. Metabolism. 1996; 45: 1368–74. [PubMed Abstract].
   Google Scholar
• Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008; 22: 659–61. [PubMed Abstract].
   Google Scholar
• Wang X, Yao XF, Ying Y, Liu J, Wang Z. Effect of L-arabinose on glucose and lipid metabolism in type 2 diabetic rats. J Hyg Res. 2012; 41: 260–7.
   Google Scholar
• Mohamed AI, Entesar FA, Salwa AI, Walaa YA, Aly MA. Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats. Eur J Pharmacol. 2014; 724: 204–10.
   Web of Science ®Google Scholar
• DeFronzo RA. Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web. J Cardiovasc Pharmacol. 1992; 20: 1–16.
   PubMed Web of Science ®Google Scholar
• Osaki S, Kimura T, Sugimoto T, Hizukuri S, Iritani N. L-arabinose feeding prevents increases due to dietary sucrose in lipogenic enzymes and triacylglycerol levels in rats. J Nutr. 2001; 131: 796–9. [PubMed Abstract].
   Google Scholar
• Krog-Mikkelsen I, Tetens I, Holst JJ, Bukhave K. The effects of L-arabinose on intestinal sucrase activity in man. Ann Nutr Metabol. 2007; 51: 163.
   Web of Science ®Google Scholar
• Shibanuma K, Degawa Y, Houda K. Determination of the transient period of the EIS complex and investigation of the suppression of blood glucose levels by L-arabinose in healthy adults. Eur J Nutr. 2011; 50: 447–53. [PubMed Abstract].
   Google Scholar
• Jurgonski A, Krotkiewski M, Juskiewicz J, Billing-Marczak K. Suppression of postprandial glycaemia by L-arabinose in rats is more associated with starch than sucrose ingestion – short report. Pol J Food Nutr Sci. 2015; 65: 57–60.
   Web of Science ®Google Scholar
• Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes. 2005; 30: 400–18.
   Web of Science ®Google Scholar
• Winkler G, Kiss S, Keszthelyi L, Sapi Z, Ory I, Salamon F, etal. Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol. 2003; 149: 129–35. [PubMed Abstract].
   Google Scholar
• Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, etal. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002; 110: 1093–103. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006; 43: 99–112.
   PubMed Web of Science ®Google Scholar
• Rahimian R, MasihKhan E, Lo M, Van Breemen C, McManus BM, Dube GP. Hepatic over-expression of peroxisome proliferator activated receptor γ2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus. Mol Cell Biochem. 2001; 224: 29–37. [PubMed Abstract].
   Google Scholar
• Den BM, Voshol P, Kuipers F, Havekes L, Romijn J. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. Arterioscler Thromb Vasc Biol. 2004; 24: 644–9.
   Web of Science ®Google Scholar
• Nagasawa T, Inada Y, Nakano S, Tamura T, Takahashi T, Maruyama K, etal. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARd agonist, on development of steatohepatitis in mice fed a methionine-and choline-deficient diet. Eur J Pharmacol. 2006; 536: 182–91. [PubMed Abstract].
   Google Scholar